PCN422 BAYESIAN MODEL AVERAGING FOR EXTRAPOLATING SURVIVAL: A PAN-TUMOR PERSPECTIVE ON NIVOLUMAB AND IPILIMUMAB
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.615
https://www.valueinhealthjournal.com/article/S1098-3015(19)32993-6/fulltext
Section Title :
Section Order :
10530
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32993-6&doi=10.1016/j.jval.2019.09.615